Mastering Medical
USMLE Step 2 CK · Endocrine

Hypoglycemia vs Insulinoma

How to tell Hypoglycemia and Insulinoma apart when a board question makes them look alike.

Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.

Fastest separator

C-peptide level during hypoglycemia is the fastest branch point, because elevated C-peptide indicates endogenous insulin production.

Side by side

HypoglycemiaInsulinoma
Key clue

Symptomatic low plasma glucose that rapidly resolves with carbohydrate defines true hypoglycemia but not its cause.

Endogenous hyperinsulinemia during fasting hypoglycemia strongly suggests insulinoma.

Mechanism

Hypoglycemia reflects insufficient circulating glucose relative to tissue demand from medication, fasting, critical illness, or endocrine dysfunction.

Insulinoma is a beta-cell tumor causing autonomous insulin secretion despite low plasma glucose.

Labs and tests

Document Whipple triad with plasma glucose <55 mg/dL during symptoms, then evaluate insulin and C-peptide to classify etiology; exogenous insulin use shows high insulin with suppressed C-peptide <0.2 nmol/L.

During supervised fast, insulinoma pattern is glucose <55 mg/dL with insulin >=3 microU/mL, C-peptide >=0.6 ng/mL, proinsulin >=5 pmol/L, and negative sulfonylurea screen.

The trap

Any low glucose episode can be mislabeled as insulinoma. The resolving clue is biochemical context during a documented episode: exogenous insulin lowers glucose with low C-peptide, while insulinoma keeps C-peptide and proinsulin inappropriately elevated.

The repair move

Next best step: treat acute neuroglycopenia first with IV dextrose, then confirm endogenous hyperinsulinemia during supervised fasting if outpatient data are incomplete. After biochemical confirmation, localize tumor with contrast pancreas CT or MRI, and proceed to surgical resection when feasible. If not operable, reduce hypoglycemia frequency with frequent carbohydrate intake and medications such as diazoxide.

Try a free question

Core

A 38-year-old nurse has recurrent tremor and confusion relieved by candy. During symptoms, glucose is 40 mg/dL, insulin is elevated, and C-peptide is undetectable. What is the most likely diagnosis?

Show answer and explanation

Answer: B. Exogenous insulin use. High insulin with suppressed C-peptide during hypoglycemia indicates exogenous insulin administration.

Why the other choices are tempting

  • A. Insulinoma would produce elevated C-peptide because insulin secretion is endogenous.
  • C. Adrenal insufficiency can cause hypoglycemia but does not create this insulin and C-peptide pattern.
  • D. Reactive hypoglycemia is typically postprandial and does not show this biochemical profile.
  • E. Hypothyroidism is not associated with isolated high insulin and absent C-peptide during episodes.

Flashcards

Tap a card to flip it.

Which lab value best separates endogenous from exogenous hyperinsulinemic hypoglycemia?

C-peptide, because endogenous insulin elevates C-peptide while exogenous insulin suppresses it.

What triad confirms clinically significant hypoglycemia before etiologic workup?

Symptoms of hypoglycemia, low measured plasma glucose, and symptom relief after glucose administration.

Quick answers

What is the fastest way to tell Hypoglycemia from Insulinoma?

C-peptide level during hypoglycemia is the fastest branch point, because elevated C-peptide indicates endogenous insulin production.

What is the key clue for Hypoglycemia?

Symptomatic low plasma glucose that rapidly resolves with carbohydrate defines true hypoglycemia but not its cause.

What is the key clue for Insulinoma?

Endogenous hyperinsulinemia during fasting hypoglycemia strongly suggests insulinoma.

What is the common trap with Hypoglycemia vs Insulinoma?

Any low glucose episode can be mislabeled as insulinoma. The resolving clue is biochemical context during a documented episode: exogenous insulin lowers glucose with low C-peptide, while insulinoma keeps C-peptide and proinsulin inappropriately elevated.